Immunogen
17D strain of yellow virus.
Application
Neutralization (BLK) Asibi YF; 1:1000-1:3000.
Hemagglutination-inhibition: 1:3000-1:6000.
Hemagglutination-inhibition: 1:3000-1:6000.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Yellow Fever Virus Antibody, clone 2D12.A is validated for use in HI, NEUT for the detection of Yellow Fever Virus.
Biochem/physiol Actions
Reacts with the envelope protein of the wild (Asibi) and vaccine strains of yellow fever virus. Preferentially neutralizes the Asibi strain. No cross-reactivity with other flaviviruses has been demonstrated.
Physical form
Ascites.
Preparation Note
Maintain at -20°C for up to 12 months from date of receipt. Avoid repeated freeze/thaw cycles.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
存储类别
10 - Combustible liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Yellow Fever-induced Acute Lung Injury.
Alexandre Todorovic Fabro et al.
American journal of respiratory and critical care medicine, 200(2), 250-252 (2019-02-26)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持